Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

bioAffinity Technologies (BIAF) Preferred Shares (2025 - 2026)

bioAffinity Technologies has reported Preferred Shares over the past 2 years, most recently at $1.0 for Q1 2026.

  • Quarterly Preferred Shares changed N/A to $1.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.0 through Mar 2026, changed N/A year-over-year, with the annual reading at $1.0 for FY2025, N/A changed from the prior year.
  • Preferred Shares was $1.0 for Q1 2026 at bioAffinity Technologies, roughly flat from $1.0 in the prior quarter.
  • Over five years, Preferred Shares peaked at $1.0 in Q3 2025 and troughed at $1.0 in Q3 2025.